MARKET

AMLX

AMLX

Amylyx Pharmaceuticals
NASDAQ
12.56
-0.54
-4.12%
After Hours: 13.45 +0.89 +7.09% 19:18 12/15 EST
OPEN
13.25
PREV CLOSE
13.10
HIGH
13.41
LOW
12.41
VOLUME
1.51M
TURNOVER
--
52 WEEK HIGH
16.96
52 WEEK LOW
2.600
MARKET CAP
1.38B
P/E (TTM)
-6.9793
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AMLX last week (1208-1212)?
Weekly Report · 22h ago
Analysts Offer Insights on Healthcare Companies: IDEAYA Biosciences (IDYA), Amylyx Pharmaceuticals Inc (AMLX) and PACS Group Inc (PACS)
TipRanks · 3d ago
Is Amylyx Pharmaceuticals (AMLX) Overvalued After Its 250% Year‑to‑Date Share Price Surge?
Simply Wall St · 6d ago
Amylyx Pharmaceuticals Inc (AMLX) Receives a Buy from Mizuho Securities
TipRanks · 12/08 10:55
Weekly Report: what happened at AMLX last week (1201-1205)?
Weekly Report · 12/08 09:02
Should Amylyx’s Clean Early AMX0114 ALS Data Shape How Investors View Its Pipeline Strategy (AMLX)?
Simply Wall St · 12/08 08:11
Positive Buy Rating for Amylyx Pharmaceuticals Based on Promising Phase I LUMINA Study Results and Strategic Advancements
TipRanks · 12/05 19:25
BUZZ-U.S. STOCKS ON THE MOVE-Omnicom, Albemarle, energy companies
Reuters · 12/05 19:14
More
About AMLX
Amylyx Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on three investigational therapies across several neurodegenerative and endocrine diseases. Its lead investigational asset is avexitide, an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist. Avexitide has been evaluated as a treatment for Post-Bariatric Hypoglycemia (PBH) and congenital HI, two indications characterized by hyperinsulinemic hypoglycemia. In addition to avexitide, it is advancing AMX0035, an oral, fixed-dose combination of sodium phenylbutyrate and taurursodiol in Wolfram syndrome and progressive supranuclear palsy (PSP), and AMX0114 in amyotrophic lateral sclerosis (ALS). AMX0035 is designed to mitigate neurodegeneration by targeting endoplasmic reticulum stress and mitochondrial dysfunction, two cellular processes central to neuronal cell death and neurodegeneration. AMX0114 is an investigational antisense oligonucleotide.

Webull offers Amylyx Pharmaceuticals Inc stock information, including NASDAQ: AMLX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMLX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMLX stock methods without spending real money on the virtual paper trading platform.